Pharmacokinetics of ritonavir and saquinavir in a haemodialysis patient [1]

Nephron

Volumn 87, Issue 2, 2001, Pages 186-187

  Izzedine, Hassane ^a   Launay Vacher, Vincent ^a   Legrand, Mayeule ^a   Aymard, Guy ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RITONAVIR; SAQUINAVIR;

ADULT; AREA UNDER THE CURVE; BLOOD SAMPLING; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; HEMODIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY FAILURE; LETTER; LIVER CLEARANCE; MALE; PRIORITY JOURNAL; VIRUS LOAD;

AIDS-ASSOCIATED NEPHROPATHY; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RITONAVIR; SAQUINAVIR;

EID: 0035106870     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045910     Document Type: Letter

References (6)

1. Ritonavirsaquinavir combination treatment in HIV-infected patients
2. Antiviral therapy for HIV patients with renal insufficiency
3. Dosage adjustment of anti-retroviral agents in patients with organ dysfunction
4. Ritonavir pharmacokinetics alone and in combination with saquivanir in HIV-infected patients
5. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease
6. Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients